StockTipsArenaBeta

BUY Alembic Pharmaceuticals Limited — BOB Capital Markets

BUYAlembic Pharmaceuticals Limited
Alembic Pharmaceuticals share price target & all analyst calls

byBOB Capital MarketsHorizon: NA (inferred 1 year)5 Nov 2025via Institutional / Brokerage Research

Entry₹960.7Inferred
Target₹1,136
Total upside +18.25%
Stop lossNot given
CMP₹787.9513h ago
Active-17.98%+44.17%upside left 14d left
Follow BOB Capital Markets for new calls(63% target hit, 356 closed calls)Get alertsWatch APLLTD for new buy/sell callsGet alertsSee 2 other Long-term calls on APLLTDSee 161 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 22 Oct, 5:49 am IST
18 supporting7 neutral1 opposing
Supports the BUY call (18)

Alembic Pharmaceuticals received final approval from the USFDA for Ciprofloxacin and Dexamethasone Otic Suspension.

BSE · Company Update·17 Oct · 4d ago

(opens in new tab)

1 other SEBI-registered advisor has an active long-term BUY call on this stock

Advisor consensus · same horizon·5 Nov · 12mo ago

Neutral / worth noting (7)

Nothing found in this tip’s window yet.

Weighs against the BUY call (1)

Long-term trend bearish — 200-day average falling over the past quarter

Technicals · trend·21 Oct · yesterday

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Alembic Pharmaceuticals

All analyst calls on Alembic Pharmaceuticals

More from BOB Capital Markets

Every call and its outcome